Pfizer Saidal Manufacturing S.p.A.
Pfizer Saidal Manufacturing S.p.A., commonly referred to as Saidal, is a prominent player in the pharmaceutical industry, headquartered in Algeria (DZ). Established in the early 1990s, the company has made significant strides in the production of high-quality generic medications and active pharmaceutical ingredients (APIs), catering to both local and international markets. With a strong focus on research and development, Saidal has developed a diverse portfolio that includes essential medicines across various therapeutic areas, such as oncology, cardiology, and infectious diseases. The company is recognised for its commitment to quality and innovation, positioning itself as a key contributor to Algeria's healthcare landscape. Saidal's strategic partnerships and collaborations have further solidified its market position, enabling it to achieve notable milestones in production capacity and regulatory compliance. As a leader in the pharmaceutical sector, Pfizer Saidal Manufacturing S.p.A. continues to enhance access to vital healthcare solutions.
DitchCarbon Score
How does Pfizer Saidal Manufacturing S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Saidal Manufacturing S.p.A.'s score of 47 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer Saidal Manufacturing S.p.A.'s reported carbon emissions
Pfizer Saidal Manufacturing S.p.A., headquartered in Algeria (DZ), currently does not have publicly available carbon emissions data for recent years. As such, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Pfizer Saidal may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Pfizer Saidal to establish clear climate commitments and reduction initiatives to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pfizer Saidal Manufacturing S.p.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
